A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Halpern, AB; Othus, M; Huebner, EM; Orlowski, KF; Scott, BL; Smith, HA; Becker, PS; Percival, M-EM; Hendrie, PC; Perdue, AM; Chen, TL; Buckley, SA; Erba, HP; Estey, EH; Walter, RB

Published Date

  • December 2, 2016

Published In

Volume / Issue

  • 128 / 22

Published By

Pages

  • 6

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 3, 2016

Conference End Date

  • December 6, 2016